Literature DB >> 7722126

Anatomic and physiologic heterogeneity in patients with syndrome X: an intravascular ultrasound study.

J G Wiedermann1, A Schwartz, M Apfelbaum.   

Abstract

OBJECTIVES: We used intravascular ultrasound imaging of the epicardial vessels to assess coronary morphology, vasomotor response to exercise and exercise-vasomotion after beta-adrenoceptor blockade in patients with syndrome X.
BACKGROUND: Syndrome X is defined as chest pain, abnormal exercise test results and normal coronary angiographic findings. Because of the limitations of coronary angiography, intravascular ultrasound was used to define coronary pathophysiology.
METHODS: Thirty patients with syndrome X were studied with intravascular ultrasound imaging (30 MHz, 4.3F catheter) of all three major epicardial vessels. Supine arm exercise was performed during coronary imaging. Lumen area was assessed at rest and during peak exercise. The exercise-imaging protocol was repeated after loading with 0.1 mg/kg body weight of intravenous propranolol.
RESULTS: Three morphologic groups were identified using intravascular ultrasound: normal coronary arteries (no plaque, intimal thickness < 0.25 mm, n = 12), atheromatous disease (mean [+/- SD] area stenosis 37.9 +/- 7.2%, n = 10) and marked intimal thickening (0.73 +/- 0.11 mm, n = 8). Patients with normal coronary arteries displayed a vasodilatory response to exercise (+16.9% area increase); patients with abnormal coronary arteries displayed a vasoconstrictive response to exercise (-17.4% in the group with plaque; -17.6% in the group with intimal thickening). Propranolol loading attenuated the vasodilatory response in the group with normal coronary arteries (+6.4% area increase) and attenuated the vasoconstrictive response in the two groups with abnormal coronary arteries (-8.0% in the group with plaque; -8.8% in the group with intimal thickening).
CONCLUSIONS: Most patients with syndrome X have abnormal coronary arteries by intravascular ultrasound. Intravascular ultrasound identifies three distinct morphologic groups: normal coronary arteries, atheromatous plaque and intimal thickening. Exercise-vasomotion is normal in patients with syndrome X who have normal coronary arteries by ultrasound; patients with abnormal arteries (plaque or intimal thickening) have an abnormal (constrictive) response to exercise. Propranolol loading attenuates vasoreactivity in all subgroups, suggesting divergent therapeutic utility.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7722126     DOI: 10.1016/0735-1097(94)00556-6

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  9 in total

Review 1.  Cardiac syndrome X: a critical overview and future perspectives.

Authors:  G A Lanza
Journal:  Heart       Date:  2006-01-06       Impact factor: 5.994

Review 2.  Cardiac syndrome X and microvascular coronary dysfunction.

Authors:  Erika Jones; Wafia Eteiba; Noel Bairey Merz
Journal:  Trends Cardiovasc Med       Date:  2012-09-29       Impact factor: 6.677

Review 3.  Abnormal cardiac nerve function in syndrome X.

Authors:  G A Lanza
Journal:  Herz       Date:  1999-04       Impact factor: 1.443

4.  Prognostic predictors and outcomes in patients with abnormal myocardial perfusion imaging and angiographically insignificant coronary artery disease.

Authors:  Fadi Alqaisi; Firas Albadarin; Zehra Jaffery; Leonidas Tzogias; Muath Dawod; Gordon Jacobsen; Karthik Ananthasubramaniam
Journal:  J Nucl Cardiol       Date:  2008-07-31       Impact factor: 5.952

5.  Cardiac syndrome X: Clinical characteristics revisited.

Authors:  Babu Ezhumalai; Ajith Ananthakrishnapillai; Raja J Selvaraj; Santhosh Satheesh; Balachander Jayaraman
Journal:  Indian Heart J       Date:  2015-06-04

Review 6.  Intravascular ultrasound assessment of atherosclerosis.

Authors:  Antoine Guédès; Jean-Claude Tardif
Journal:  Curr Atheroscler Rep       Date:  2004-05       Impact factor: 5.113

7.  Evaluation of the mean platelet volume in patients with cardiac syndrome X.

Authors:  Sait Demirkol; Sevket Balta; Murat Unlu; Uygar Cagdas Yuksel; Turgay Celik; Zekeriya Arslan; Ugur Kucuk; Mehmet Yokusoglu
Journal:  Clinics (Sao Paulo)       Date:  2012-09       Impact factor: 2.365

8.  Prothrombotic profile in patients with vasospastic or non vasospastic angina and non significant coronary stenosis.

Authors:  Jaume Figueras; Jasone Monasterio; Enric Domingo; Beatriz Meneses; Elsa Nieto; Josefa Cortadellas; David Garcia-Dorado
Journal:  Thromb J       Date:  2011-05-27

9.  The usefulness of plateletcrit to predict cardiac syndrome X in patients with normal coronary angiogram.

Authors:  Muhammed Oylumlu; Mustafa Oylumlu; Murat Yuksel; Adnan Dogan; Musa Cakici; Mehmet Ozgeyik; Abdulkadir Yildiz; Celal Kilit; Basri Amasyali
Journal:  Postepy Kardiol Interwencyjnej       Date:  2015-09-28       Impact factor: 1.426

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.